Above and Beyond Cancer Therapy: Translating Biomaterials into the Clinic

Research output: Contribution to journalShort surveypeer-review

1 Citation (Scopus)

Abstract

Given extensive reports of anticancer nanomedicines in preclinical studies, why is there such a paucity of clinical trials using these therapies? Nanotechnology can certainly deliver, but we need to tackle the limitations that are impeding the translation of nanomedicines into the clinic and start benefiting from their full potential.

Original languageEnglish
Pages (from-to)730-732
JournalTrends in Cancer
Volume6
Issue number9
Early online date16 May 2020
DOIs
Publication statusPublished - Sep 2020

Keywords

  • biomaterials
  • cancer therapy
  • clinical translation
  • nanomedicine

Fingerprint Dive into the research topics of 'Above and Beyond Cancer Therapy: Translating Biomaterials into the Clinic'. Together they form a unique fingerprint.

Cite this